<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Pharmaceutical Commerce articles</title><description>Pharmaceutical Commerce articles</description><link>https://www.pharmaceuticalcommerce.com/news</link><category>Pharmaceutical Commerce articles</category><copyright>© 2026 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.</copyright><lastBuildDate>Tue, 20 Jan 2026 02:37:48 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.pharmaceuticalcommerce.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Pharmaceutical Commerce articles</title><width>144</width><height>47</height><link>https://www.pharmaceuticalcommerce.com/news</link><url>https://www.pharmaceuticalcommerce.com/logo.webp</url></image><item><title>&lt;![CDATA[BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/boomrx-expands-access-to-oral-semaglutide-and-tirzepatide-using-nanoemulsion-delivery</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/boomrx-expands-access-to-oral-semaglutide-and-tirzepatide-using-nanoemulsion-delivery</guid><description>&lt;![CDATA[The platform is helping to improve absorption, consistency, and scalable care delivery.]]&gt;</description><pubDate>Mon, 19 Jan 2026 17:17:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[The Hidden Economics of Health Insurance Affordability]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/the-hidden-economics-health-insurance-affordability</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/the-hidden-economics-health-insurance-affordability</guid><description>&lt;![CDATA[In the third part of his Pharma Commerce video interview, Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, points out that from employer-paid premiums to Medicare and Medicaid subsidies, the US system relies on layered financial support to keep coverage within reach—underscoring how few individuals can realistically pay the full cost of care or insurance on their own.]]&gt;</description><pubDate>Mon, 19 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&amp;A Hits Record Low; Copay Shock Warning]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-novartis-warns-of-trade-fragmentation</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-novartis-warns-of-trade-fragmentation</guid><description>&lt;![CDATA[In today’s Pharma Pulse, Novartis calls for a shift from &quot;cost-containment&quot; to structural reform, hospital mergers hit their lowest point in 15 years, and new data warns of &quot;cost shocks&quot; driven by copay accumulators.]]&gt;</description><pubDate>Mon, 19 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Dawsongroup tcs USA Launches in the States]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/dawsongroup-tcs-usa-launches-in-the-states</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/dawsongroup-tcs-usa-launches-in-the-states</guid><description>&lt;![CDATA[The company brings its temperature-controlled Superbox to the US pharma industry, aiming to improve speed, compliance, and resilience in the cold chain process.]]&gt;</description><pubDate>Fri, 16 Jan 2026 18:51:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Affordability Strain Is Moving Up the Income Ladder]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/affordability-strain-is-moving-up-the-income-ladder</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/affordability-strain-is-moving-up-the-income-ladder</guid><description>&lt;![CDATA[In the second part of his Pharma Commerce video interview, Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, describes how rising healthcare and living costs are expanding financial hardship beyond traditional eligibility thresholds, while safety-net resources shrink and demand accelerates.]]&gt;</description><pubDate>Fri, 16 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Trump’s New Healthcare Roadmap, FDA Vaccine Warnings, and BPD to Lead The Agency Network]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-trump-new-healthcare-roadmap</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-trump-new-healthcare-roadmap</guid><description>&lt;![CDATA[In today’s Pharma Pulse, President Trump unveils a patient payment plan, the FDA flags a rare seizure risk for several leading flu vaccines, and MJH Life Sciences expands its data-driven reach.]]&gt;</description><pubDate>Fri, 16 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&amp;A, and GLP-1 Market Shifts]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/evaluate--2026-pharma-forecast-signals-cautious-recovery</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/evaluate--2026-pharma-forecast-signals-cautious-recovery</guid><description>&lt;![CDATA[The company’s latest preview report projects a guarded rebound for biopharma, as investor confidence returns and M&amp;amp;A activity accelerates.]]&gt;</description><pubDate>Thu, 15 Jan 2026 20:59:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Premium Inflation Is Reshaping Patient Access and Adherence]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/premium-inflation-is-reshaping-patient-access-and-adherence</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/premium-inflation-is-reshaping-patient-access-and-adherence</guid><description>&lt;![CDATA[In the first part of his Pharma Commerce video interview, Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, explains how mounting financial pressure is forcing patients to ration care, undermining treatment adherence and accelerating downstream clinical and economic risk.]]&gt;</description><pubDate>Thu, 15 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Navigating the New Era of Healthcare]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-navigating-the-new-era-of-healthcare</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-navigating-the-new-era-of-healthcare</guid><description>&lt;![CDATA[In today’s Pharma Pulse, AbbVie joins TrumpRx, shingles vaccines reveal a longevity boost, and HER2 therapies break new ground in cancer treatment.]]&gt;</description><pubDate>Thu, 15 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[AbbVie Joins TrumpRx in Exchange for Tariff Relief and Pricing Flexibility]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/abbvie-joins-trumprx-in-exchange-for-tariff-relief-pricing-flexibility</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/abbvie-joins-trumprx-in-exchange-for-tariff-relief-pricing-flexibility</guid><description>&lt;![CDATA[The company will participate in the Trump administration’s direct-to-patient drug platform, while committing $100 billion to US R&amp;amp;D and manufacturing.]]&gt;</description><pubDate>Wed, 14 Jan 2026 16:39:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma’s US Manufacturing Push Faces a Long Investment Horizon]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-us-manufacturing-push-faces-long-investment-horizon</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-us-manufacturing-push-faces-long-investment-horizon</guid><description>&lt;![CDATA[In the final part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, explains that with plant buildouts and validation requiring three to five years, today’s reshoring momentum reflects near-term policy pressures, but global demand and overseas biosimilar growth will ultimately shape the industry’s next phase.]]&gt;</description><pubDate>Wed, 14 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Precision Cancer Care]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-precision-cancer-care</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-precision-cancer-care</guid><description>&lt;![CDATA[In today’s Pharma Pulse, Novartis expands its US radioligand footprint, and 15,000 New York City nurses go on strike.]]&gt;</description><pubDate>Wed, 14 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Novartis to Build Fourth US Radioligand Therapy Facility to Strengthen Supply Chain]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/novartis-to-build-fourth-us-radioligand-therapy-facility</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/novartis-to-build-fourth-us-radioligand-therapy-facility</guid><description>&lt;![CDATA[The pharma giant will invest in a 35,000-square-foot RLT manufacturing site in Winter Park, FL as part of its $23 billion US infrastructure expansion.]]&gt;</description><pubDate>Tue, 13 Jan 2026 17:09:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Managing Tariff-Driven Cost Increases Without Disrupting Customers]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/managing-tariff-driven-cost-increases-without-disrupting-customers</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/managing-tariff-driven-cost-increases-without-disrupting-customers</guid><description>&lt;![CDATA[In the third part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, shares how automatic contract adjustments tied to labor, energy, and inflation—combined with the critical role of supply reliability—allow the company to pass through limited surcharges while maintaining strong client relationships.]]&gt;</description><pubDate>Tue, 13 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Amazon Pharmacy Sells Oral Wegovy, J&amp;J’s Billion-Dollar Hub, and the Debt-Housing Crisis]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-amazon-weight-loss-pivot</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-amazon-weight-loss-pivot</guid><description>&lt;![CDATA[In today’s Pharma Pulse, Amazon Pharmacy launches Novo&apos;s first oral Wegovy pill with transparent cash pricing, Johnson &amp;amp; Johnson triples down on North Carolina manufacturing, and new clinical data links medical debt to rising eviction risks.]]&gt;</description><pubDate>Tue, 13 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Amazon Pharmacy Adds FDA-Approved Wegovy Pill, the First Oral GLP-1 for Weight Loss]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/amazon-pharmacy-adds-fda-approved-wegovy-pill</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/amazon-pharmacy-adds-fda-approved-wegovy-pill</guid><description>&lt;![CDATA[Novo Nordisk’s newly approved oral semaglutide is now available nationwide through Amazon Pharmacy with insurance and cash-pay options.]]&gt;</description><pubDate>Mon, 12 Jan 2026 16:35:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why US-Based Manufacturing Is Becoming a Strategic Imperative for Biopharma]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-us-based-manufacturing-is-becoming-a-strategic-imperative-for-biopharma</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-us-based-manufacturing-is-becoming-a-strategic-imperative-for-biopharma</guid><description>&lt;![CDATA[In the second part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, describes how from FDA validation to dual-site redundancy and reshoring momentum, the expansion of US capacity is a competitive advantage for pharma clients navigating increasingly complex global supply chains.]]&gt;</description><pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: J&amp;J Enters TrumpRx and the Red Flags in Pediatric Vaccines]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-j-j-enters-trumprx</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-j-j-enters-trumprx</guid><description>&lt;![CDATA[In today’s Pharma Pulse, Johnson &amp;amp; Johnson secures a major tariff deal by joining the federal drug discount portal, while new data warns that missing early infant shots is the leading predictor of skipped MMR vaccines.]]&gt;</description><pubDate>Mon, 12 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Johnson &amp; Johnson Joins TrumpRx to Lower Drug Prices, Secures Tariff Exemption]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/johnson-johnson-joins-trumprx</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/johnson-johnson-joins-trumprx</guid><description>&lt;![CDATA[The pharma giant becomes the latest manufacturer to participate in the Trump Administration’s direct-to-patient pricing platform, aligning US drug costs with European benchmarks while reinforcing its domestic manufacturing investments.]]&gt;</description><pubDate>Fri, 09 Jan 2026 19:05:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Tariffs Nudge Pharma Toward Localization, but Supply Chains Can’t Shift Overnight]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/tariffs-nudge-pharma-toward-localization</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/tariffs-nudge-pharma-toward-localization</guid><description>&lt;![CDATA[In the first part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, explains how near-term tariff pressures are creating short-term headwinds while accelerating longer-term investment in regional manufacturing footprints—especially in the US.]]&gt;</description><pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Merger Fever, Lilly’s $1.2B Inflammatory Bet, and the Birth of CareTria]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-merger-fever</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-merger-fever</guid><description>&lt;![CDATA[In today’s Pharma Pulse, healthcare leaders brace for a surge in dealmaking, Eli Lilly secures a suite of oral NLRP3 inhibitors, and Knipper Health rebrands to streamline the path from order to therapy.]]&gt;</description><pubDate>Fri, 09 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Knipper Health Rebrands as CareTria to Expand Integrated Therapy Initiation Platform]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/knipper-health-rebrands-as-caretria</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/knipper-health-rebrands-as-caretria</guid><description>&lt;![CDATA[Backed by Frazier Healthcare Partners and strengthened by the acquisition of eBlu Solutions, CareTria aims to accelerate patient access by combining provider technology, digital enrollment, and multi-modal fulfillment into a single end-to-end platform.]]&gt;</description><pubDate>Thu, 08 Jan 2026 16:14:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[What Will Actually Bend the Healthcare Cost Curve?]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/what-will-actually-bend-the-healthcare-cost-curve-</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/what-will-actually-bend-the-healthcare-cost-curve-</guid><description>&lt;![CDATA[In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, points out that from biosimilars and site-of-care shifts to AI, value-based reimbursement, and potential legislative action, market deflators—not simple cost shifting—will determine whether affordability improves across employer-sponsored plans, Medicaid, and Medicare.]]&gt;</description><pubDate>Thu, 08 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: FDA Fast-Tracks Merck Blockbusters, GSK’s Precision Data Bet, and DHL’s Massive PA Hub]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-fda-fast-tracks-merck-blockbusters</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-fda-fast-tracks-merck-blockbusters</guid><description>&lt;![CDATA[In today’s Pharma Pulse, the FDA issues two high-stakes priority vouchers for cholesterol and cancer therapies, GSK leverages genomic data to refine drug targets, and DHL completes a one-million-square-foot logistics center of excellence.]]&gt;</description><pubDate>Thu, 08 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[DHL Supply Chain Opens 1-Million-Square-Foot Life Sciences Distribution Center in Pennsylvania, Expanding Healthcare Logistics Footprint]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/dhl-supply-chain-opens-1-million-square-foot-life-sciences-distribution-center</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/dhl-supply-chain-opens-1-million-square-foot-life-sciences-distribution-center</guid><description>&lt;![CDATA[A new Foreign Trade Zone–enabled facility in Annville strengthens the company’s temperature-controlled, compliant logistics capabilities, while accelerating customs processing and last-mile healthcare delivery.]]&gt;</description><pubDate>Wed, 07 Jan 2026 16:23:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why Employers Are Passing More Healthcare Costs to Workers]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-employers-are-passing-more-healthcare-costs-to-workers</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-employers-are-passing-more-healthcare-costs-to-workers</guid><description>&lt;![CDATA[In the third part of his Pharma Commerce video interview, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, explains as medical inflation persists and benefit designs strain under rising drug spend—especially GLP-1s—employers are reaching the limits of what they can absorb, accelerating cost-shifting and fragmenting how employees pay for care.]]&gt;</description><pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Pediatric Vaccine Revisions, COPD Mortality Trends, and Eli Lilly’s $1.3B Obesity Deal]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-pediatric-vaccine-revisions</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-pediatric-vaccine-revisions</guid><description>&lt;![CDATA[In today’s Pharma Pulse, federal officials slash the childhood immunization schedule, new data underscores the life-saving impact of COVID vaccines for COPD patients, and Eli Lilly targets the AMPK pathway in a massive new oral obesity collaboration.]]&gt;</description><pubDate>Wed, 07 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[What the Closure of a Single Plant Reveals About US Drug Resilience]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/what-the-closure-of-a-single-plant-reveals-about-us-drug-resilience</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/what-the-closure-of-a-single-plant-reveals-about-us-drug-resilience</guid><description>&lt;![CDATA[Merck’s decision to shutter its Riverside, PA antibiotic API facility underscores how decades of cost-driven optimization have eroded domestic manufacturing of essential medicines—exposing systemic vulnerabilities in US drug supply resilience that markets alone are unlikely to fix.]]&gt;</description><pubDate>Tue, 06 Jan 2026 15:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[How Public Policy Shifts Are Reshaping Employer Healthcare Costs]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/how-public-policy-shifts-are-reshaping-employer-healthcare-costs</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/how-public-policy-shifts-are-reshaping-employer-healthcare-costs</guid><description>&lt;![CDATA[In the second part of his Pharma Commerce video interview, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, points out that a Medicaid spending tightens and ACA subsidies lapse, reduced public coverage is driving spillover effects—shifting costs to hospitals, employers, and commercial drug pricing in an increasingly interconnected healthcare market.]]&gt;</description><pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: GoodRx Rollout for Oral Wegovy; Major Reprieve for 340B Hospitals; Sanofi’s $2.5B AI Bet]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-goodrx-rollout-for-oral-wegovy</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-goodrx-rollout-for-oral-wegovy</guid><description>&lt;![CDATA[In today’s Pharma Pulse, GoodRx slashes cash prices for the new Wegovy pill, a federal judge halts the 340B rebate pilot, and Sanofi doubles down on Earendil Labs’ AI platform for autoimmune breakthroughs.]]&gt;</description><pubDate>Tue, 06 Jan 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item></channel></rss>